Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Could the UK become a medicinal cannabis leader?
A new review has outlined 20 recommendations for how the UK can become a world leader in cannabinoid innovation. But is it possible?
Pfizer joins GSK in RSV success
Pfizer plans to file for approval for its RSV vaccine for infants by the end of 2022 after achieving positive Phase 3 results.
Pharma insights from the team behind GOLD
Listen to the GOLD team: Helena, Isabel and Jade will discuss key articles, themes and insights from the latest issue of GOLD.
How is pharma improving animal testing – and what do activists think?
The pharmaceutical industry has been trying to refine, reduce and replace animal testing for some time, but animal rights activists argue progress is too incremental.
Pharma's response to Roe v. Wade
The overturning of Roe v. Wade is impacting access to medical abortion, but in what ways is pharma trying to help?
31st October 2022
Retracted: Building on a Strong Foundation to Address a New Era to Help Protect Against Pneumococcal Disease
Ramirez noted that more than 100 pneumococcal serotypes have now been identified, which is most likely the result of increased…
31st October 2022
NUVAXOVIDᵀᴹ dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) For Individuals 12 Years and Older
Learn about NUVAXOVIDᵀᴹ dispersion for injection COVID-19 vaccine (recombinant, adjuvanted) for individuals 12 Years and older.
4
Mins
31st October 2022
Cutaneous Mucormycosis Co-infection in a Patient with COVID-19
A 54-year-old male tested positive in late February on a screening COVID-19 test performed after a family member’s test had become positive. A few weeks later, they presented to the emergency room at a different hospital centre with shortness of breath and fever.
Roundtable: behind the headlines of Inflation Reduction Act
Two US pricing experts dissect the implications of The Inflation Reduction for the pharma industry in this roundtable.
28th October 2022
Updates from the European Society for Medical Oncology 2022 Congress
This week, Jonathan Sackier is joined by Arndt Vogel to discuss his role at ESMO and key themes in cancer care from the ESMO Congress.
←
1
2
3
…
221
222
223
224
225
226
227
…
897
898
899
→